CAS: 256383-45-6; 4-N-Nonylphenylboronic Acid

该化合物是一种有机体化合物,其特征是用一种苯乙酸功能组,以非基链替换,其位置在准位置上,这种结构具有强化的亲脂性,使其在铃木-宫浦交叉反应中特别有用,在铃木-宫浦交叉反应中,它作为卤化物的高效结合伙伴发挥作用,其氢离子体链可以提高有机溶剂的溶性,便利非极化介质的反应.该化合物还被用于合成先进材料和药物,在温和条件下,其稳定性和回性是有利的.建议谨慎处理,因为其对水分和潜在水解十分敏感.

结构式图片

上下游产品

4-n-nonylbenzeneboronic acid pinacolate dihydroxy-nonyl-borane para-nitrophenyl triflate 4-nonyllphenyl benzoate

合成工艺路线路线简述

    📜4-硝基苯酚三氟甲基磺酸酯置于2-双环己基膦-2',6'-二甲氧基联苯,盐酸,Potassium Phosphate Monohydrate,Potassium Hydrogen Fluoride,Palladium On Activated Charcoal,氢气,Palladium Diacetate,三乙胺,Sodium Nitrite体系中,用 1,4-二氧六环,甲醇,乙醇,水,甲苯 用作溶剂,化学反应 1.5H,反应生成4-壬基苯硼酸
    参考文献:Design And Synthesis Of Boronic Acid Inhibitors Of Endothelial Lipase
    标题:Design And Synthesis Of Boronic Acid Inhibitors Of Endothelial Lipase
    摘要:Endothelial Lipase (El) And Lipoprotein Lipase (Lpl) Are Homologous Lipases That Act On Plasma Lipoproteins. El Is Predominantly A Phospholipase And Appears To Be A Key Regulator Of Plasma Hdl-C. Lpl Is Mainly A Triglyceride Lipase Regulating (V)Ldl Levels. The Existing Biological Data Indicate That Inhibitors Selective For El Over Lpl Should Have Anti-Atherogenic Activity,Mainly Through Increasing Plasma Hdl-C Levels. We Report Here The Synthesis Of Alkyl,Aryl,Or Acyl-Substituted Phenylboronic Acids That Inhibit El. Many Of The Inhibitors Evaluated Proved To Be Nearly Equally Potent Against Both El And Lpl,But Several Exhibited Moderate To Good Selectivity For El. (C) 2011 Elsevier Ltd. All Rights Reserved.
    Doi:10.1016/j.Bmcl.2011.12.043

    海关参考信息

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    [参考文献]: Anna Minkkilä, Et Al. Discovery Of Boronic Acids As Novel And Potent Inhibitors Of Fatty Acid Amide Hydrolase. J Med Chem. 2008 Nov 27;51(22):7057-60.

    合成参考文献


    参考文献:10.1038/s41419-023-05779-z
    摘要:Hao J, Chen Q, Feng Y, Jiang Q, Sun H, Deng B, Huang X, Guan J, Chen Q, Liu X, Wang Y, Cao P, Feng F, Li X. Combination treatment with FAAH inhibitors/URB597 and ferroptosis inducers significantly decreases the growth and metastasis of renal cell carcinoma cells via the PI3K-AKT signaling pathway. Cell Death Dis. 2023 Apr 06;14(4):247.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知